Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Johnson & Johnson (JNJ)  
$152.67 1.29 (0.85%) as of 4:30 Wed 5/15


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,630,000,000
Market Cap: 401.52(B)
Last Volume: 5,547,802 Avg Vol: 8,309,807
52 Week Range: $144.45 - $174.48
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  21
Guru Rank Value     : 20.3
Guru Occurances    : 6

 

            6 Months   1 Year   2 Year  
 
Company Profile   Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 8,891 68,288 115,451 522,170
Total Sell Value $1,441,765 $10,723,734 $18,652,688 $88,845,171
Total People Sold 1 2 5 10
Total Sell Transactions 1 2 5 24
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 606
  Page 19 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Gorsky Alex Chairman, CEO   •       •      –    2017-12-04 4 GD $0.00 $0 D/D 7,153 252,825     -
   Stoffels Paulus Exec VP, Chief Scientific Off   •       •      –    2017-10-31 4 D $139.54 $4,847,899 D/D (34,742) 168,400     -
   Stoffels Paulus Exec VP, Chief Scientific Off   •       •      –    2017-10-31 4 OE $0.00 $0 D/D 75,492 203,142     -
   Perez William D Director   •       •      –    2017-10-24 4 GD $0.00 $0 I/I 2,400 9,100     -
   Stoffels Paulus Exec VP, Chief Scientific Off   •       •      –    2017-07-24 4 S $133.14 $13,672,629 D/D (102,692) 127,650     -
   Stoffels Paulus Exec VP, Chief Scientific Off   •       •      –    2017-07-24 4 OE $72.54 $7,449,278 D/D 102,692 230,342     -
   Caruso Dominic J Exec VP, Finance; CFO   •       •      –    2017-07-20 4 S $136.72 $11,291,478 D/D (82,591) 144,102     -
   Caruso Dominic J Exec VP, Finance; CFO   •       •      –    2017-07-20 4 OE $61.75 $5,099,994 D/D 82,591 226,693     -
   Ullmann Michael H Exec VP, General Counsel   •       •      –    2017-05-10 4 GD $0.00 $0 D/D 409 109,483     -
   Pruden Gary J Exec VP, WW Chair, Med Devices   •       •      –    2017-02-28 4 S $122.21 $1,991,943 D/D (16,299) 43,630     -
   Ullmann Michael H Exec VP, General Counsel   •       •      –    2017-02-27 4 GD $0.00 $0 D/D 208 109,892     -
   Stoffels Paulus Exec VP, Chief Scientific Off   •       •      –    2017-02-15 4 S $117.29 $2,580,274 D/D (22,000) 127,650     -
   Duato Joaquin Exec VP, WW Chair, Pharma   •       •      –    2017-02-13 4 D $115.67 $1,870,962 D/D (16,175) 68,536     -
   Duato Joaquin Exec VP, WW Chair, Pharma   •       •      –    2017-02-13 4 A $0.00 $0 D/D 8,897 84,711     -
   Duato Joaquin Exec VP, WW Chair, Pharma   •       •      –    2017-02-13 4 OE $0.00 $0 D/D 22,298 75,814     -
   Pruden Gary J Exec VP, WW Chair, Med Devices   •       •      –    2017-02-13 4 D $115.67 $1,118,876 D/D (9,673) 59,929     -
   Pruden Gary J Exec VP, WW Chair, Med Devices   •       •      –    2017-02-13 4 A $0.00 $0 D/D 6,197 69,602     -
   Pruden Gary J Exec VP, WW Chair, Med Devices   •       •      –    2017-02-13 4 OE $0.00 $0 D/D 15,532 63,405     -
   Kapusta Ronald A Controller, CAO   •       •      –    2017-02-13 4 D $115.67 $109,308 D/D (945) 29,964     -
   Kapusta Ronald A Controller, CAO   •       •      –    2017-02-13 4 A $0.00 $0 D/D 857 30,909     -
   Kapusta Ronald A Controller, CAO   •       •      –    2017-02-13 4 OE $0.00 $0 D/D 2,148 30,052     -
   Ullmann Michael H Exec VP, General Counsel   •       •      –    2017-02-13 4 D $115.67 $1,225,061 D/D (10,591) 110,100     -
   Ullmann Michael H Exec VP, General Counsel   •       •      –    2017-02-13 4 A $0.00 $0 D/D 5,825 120,691     -
   Ullmann Michael H Exec VP, General Counsel   •       •      –    2017-02-13 4 OE $0.00 $0 D/D 14,600 114,866     -
   Fasolo Peter Exec VP, Chief HR Officer   •       •      –    2017-02-13 4 D $115.67 $1,267,859 D/D (10,961) 64,162     -

  606 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 19 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed